The journey from a laboratory hypothesis to a pharmacy shelf is one of the most grueling marathons in modern industry, typically spanning 10 to 15 years and billions of dollars in investment. Progress [...]
Alphabet's life sciences business Verily is restructuring and raising money as a new corporate entity. Verily announced that with its $300 million investment round, it will change from an LLC to [...]
OpenAI has introduced GPT-Rosalind, a reasoning model tailored for the life sciences. It's designed to help researchers move faster from hypothesis to experiment. Access is tightly controlled for [...]